These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2214236

  • 1. [The correlations of respiratory function tests, chest roentgenographic manifestations and respiratory symptoms in the patients with systemic sclerosis, using a scoring-method for symptoms].
    Kikuchi K, Igarashi A, Ishibashi Y, Inokuma S, Takehara K.
    Nihon Hifuka Gakkai Zasshi; 1990 May; 100(6):695-700. PubMed ID: 2214236
    [Abstract] [Full Text] [Related]

  • 2. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [Abstract] [Full Text] [Related]

  • 3. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G, De Nardo D, Capria A, Manenti G, Fabiano S, Borzi M, De Sanctis G, Konda D, Sperandio M, Schillaci O, Masala S, Simonetti G, Fontana L.
    In Vivo; 2004 Jun; 18(2):229-35. PubMed ID: 15113051
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary functions in children with progressive systemic sclerosis.
    Garty BZ, Athreya BH, Wilmott R, Scarpa N, Doughty R, Douglas SD.
    Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group.
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [Abstract] [Full Text] [Related]

  • 8. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K, Gharibdoost F, Parastandechehr G, Salehian P.
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
    Celebi Sözener Z, Karabıyıkoğlu G, Düzgün N.
    Tuberk Toraks; 2010 Dec; 58(3):235-41. PubMed ID: 21038133
    [Abstract] [Full Text] [Related]

  • 11. Lung involvement in systemic sclerosis.
    Silver RM, Miller KS.
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.
    Vañó Sanchis D, Arranz Garcia G, Yglesias PJ.
    Clin Rheumatol; 2006 May; 25(3):382-3. PubMed ID: 16211337
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pulmonary involvement in sclerodermia].
    Paone G, Di Michele L, Mattia P, Tonnarini R, Lucifora V, Fiorucci F.
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
    Wells AU, Steen V, Valentini G.
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary function in patients with systemic sclerosis.
    Spagnolatti L, Zoia MC, Volpini E, Convertino G, Fulgoni P, Corsico A, Vitulo P, Cerveri I.
    Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.